1 / 38

Serologic markers in the diagnosis of irritable bowel disease

To evaluate the utility of serologic markers in the diagnosis of IBD. Background on IBDCurrent criteria for IBD diagnosisEvidence for serology in IBDCase study at MCGSerology: adjunct or screening toolConclusion. IBD . Spectrum of chronic relapsing disorders affecting GI tractCrohn disease

kalonice
Download Presentation

Serologic markers in the diagnosis of irritable bowel disease

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Serologic markers in the diagnosis of irritable bowel disease 7 September 2006 Roni J Bollag

    2. To evaluate the utility of serologic markers in the diagnosis of IBD Background on IBD Current criteria for IBD diagnosis Evidence for serology in IBD Case study at MCG Serology: adjunct or screening tool Conclusion

    3. IBD Spectrum of chronic relapsing disorders affecting GI tract Crohn disease Ulcerative colitis Indeterminate colitis Lifelong disease beginning in youth (15-30) Prevalence: 15 -20% (North America) Immunologically mediated disease in genetically susceptible hosts

    4. IBD – consensus criteria Chief symptom: abdominal pain with altered bowel habits Rome criteria

More Related